{
    "clinical_study": {
        "@rank": "67040", 
        "arm_group": [
            {
                "arm_group_label": "women with breast cancer", 
                "description": "This study is a prospective, observational, longitudinal study assessing the prevalence of sexual dysfunction and distress in premenopausal women with breast cancer. This study will also evaluate the severity, time course, and predictors of sexual dysfunction. Breast cancer patients and survivors will be administered surveys of comprehensive questionnaires related to sexual function."
            }, 
            {
                "arm_group_label": "women with lymphoma", 
                "description": "This study is a prospective, observational, longitudinal study assessing the prevalence of sexual dysfunction and distress in premenopausal women with   Diffuse Large B-cell Lymphoma or Hodgkin's Lymphoma. This study will also evaluate the severity, time course, and predictors of sexual dysfunction. Lymphoma patients and survivors will be administered surveys of comprehensive questionnaires related to sexual function."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to see how cancer treatment affects sexual and reproductive\n      function."
        }, 
        "brief_title": "Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Breast Cancer", 
            "Lymphoma", 
            "Hodgkin's Lymphoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Hodgkin Disease", 
                "Lymphoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant\n             or had at least one menstrual period in the last 12 months\n\n          -  Women with newly diagnosed breast cancer (stage 0-III) or Diffuse Large B-cell\n             Lymphoma or Hodgkin's Lymphoma within 1 month of starting systemic treatment\n\n          -  Breast cancer patients with any receptor type\n\n          -  English speaking\n\n          -  Able to participate in the informed consent process\n\n        Exclusion Criteria:\n\n          -  Active secondary cancer requiring cytotoxic chemotherapy\n\n          -  Prior systemic treatment for a malignancy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women ages 18 to 50, who are premenopausal with a new diagnosis of stage 0-III breast\n        cancer or Diffuse Large B-cell Lymphoma or Hodgkin's Lymphoma will be recruited from\n        breast cancer and lymphoma clinics."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01788839", 
            "org_study_id": "12-249"
        }, 
        "intervention": {
            "arm_group_label": [
                "women with breast cancer", 
                "women with lymphoma"
            ], 
            "description": "A survey including the Female Sexual Function Index (FSFI), the Modified Female Sexual Function Index (FSFI-M), the Sexual Activity Questionnaire (SAQ), the Female Sexual Distress Scale (FSDS-R), the Menopausal Symptom Check List (MSCL), Patient-reported Outcomes Measurement Information System Sexual Function Instrument (PROMIS-SF), Abbreviated Dyadic Adjustment Scale for Relationships (ADAS), Reproductive Health Survey-baseline (RHS-B). Reproductive Health Survey-followup and (RHS-F1)Reproductive Health Survey-followup (RHS-F2) will be conducted at the following intervals: baseline/before chemotherapy +/- 1 month, 3 months after baseline +/- 1 month, 6 months after baseline +/- 1 month, 1 year after baseline +/- 1 month, and at intervals during survivorship that include yearly for 5 years +/- 1 month.", 
            "intervention_name": "surveys", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sexual and Reproductive Health", 
            "premenopausal", 
            "Fertility", 
            "12-249"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "link": {
            "description": "Memorial Sloan-Kettering Cancer Center", 
            "url": "http://www.mskcc.org/"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Shari Goldfarb, MD", 
                    "phone": "646-888-5080"
                }, 
                "contact_backup": {
                    "last_name": "Maura Dickler, MD", 
                    "phone": "646-888-5456"
                }, 
                "facility": {
                    "address": {
                        "city": "Basking Ridge", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07920"
                    }, 
                    "name": "Memorial Sloan-Kettering at Basking Ridge"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Shari Goldfarb, MD", 
                    "phone": "646-888-5080"
                }, 
                "facility": {
                    "address": {
                        "city": "Commack", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11725"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center @ Suffolk"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Shari Goldfarb, MD", 
                    "phone": "646-888-5080"
                }, 
                "contact_backup": {
                    "last_name": "Maura Dickler, MD", 
                    "phone": "646-888-5456"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Memorial Sloan Kettering Cancer Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Shari Goldfarb, MD", 
                    "phone": "646-888-5080"
                }, 
                "facility": {
                    "address": {
                        "city": "Rockville Centre", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Memorial Sloan-Kettering at Mercy Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Shari Goldfarb, MD", 
                    "phone": "646-888-5080"
                }, 
                "facility": {
                    "address": {
                        "city": "Sleepy Hollow", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10591"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma", 
        "overall_contact": {
            "last_name": "Shari Goldfarb, MD", 
            "phone": "646-888-5080"
        }, 
        "overall_contact_backup": {
            "last_name": "Maura Dickler, MD", 
            "phone": "646-888-5456"
        }, 
        "overall_official": {
            "affiliation": "Memorial Sloan-Kettering Cancer Center", 
            "last_name": "Shari Goldfarb, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "determine the natural history of sexual and reproductive health", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01788839"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "predictors of sexual dysfunction during and after treatment", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "impact of treatment on self-reported future pregnancy/reproductive health", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Before treatment and family building after treatment", 
                "measure": "factors that influence decisions regarding fertility preservation", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "comparison of sexual function between breast cancer and lymphoma patients", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Memorial Sloan-Kettering Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Memorial Sloan-Kettering Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2014"
    }
}